Skip to main content
Signal8

Song Paul Y.

SEC insider (Form 3/4/5 filer). CIK 0001991119. Chief Executive Officer at NKGen Biotech, Inc. (NKGN). 2 reported Form 4/5 transactions since Sep 2024; latest on May 5, 2025. Located in SANTA ANA, CA.

Companies Song Paul Y. has filed insider reports for

  • NKGen Biotech, Inc. (NKGN): Officer, Chief Executive Officer
Song Paul Y. profile photo

Song Paul Y.

CIK: 0001991119

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NKGen Biotech, Inc. logo
NKGN

NKGen Biotech, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • NKGen Biotech, Inc. logo
    NKGN

    NKGen Biotech, Inc.

    May 5, 2025
    Purchase
    Direct
    20.8M shares at avg. $0.13$2.7M
  • NKGen Biotech, Inc. logo
    NKGN

    NKGen Biotech, Inc.

    Dec 6, 2024
    Award

    Stock Option (right to buy)

    Direct
    2M shares-

1-2 of 2